BiotechTube
Home/Cassava Sciences/Eric J. Schoen
EJ

Eric J. Schoen

Chief Financial Officer

Cassava Sciences

Therapeutic Areas

Alzheimer's DiseaseNeurodegenerative Diseases

Cassava Sciences Pipeline

DrugIndicationPhase
Simufilam (PTI-125)Alzheimer's Disease DementiaPhase 3
SavaDxAlzheimer's Disease DetectionResearch

Leadership Team at Cassava Sciences

RB
Remi Barbier
President, CEO & Chairman
JS
James S. (Jim) Burns
Chief Operating Officer
LA
Lindsay A. Burns
Senior Vice President, Neuroscience
View full Cassava Sciences profile